<a href="https://laohu8.com/S/TNONW">Tenon Medical</a> Wins FDA Clearance for SImmetry+ SI Joint Fusion System
Tenon Medical Inc. has announced it has received FDA 510(k) clearance for its SImmetry+ SI Joint Fusion System. This regulatory approval expands Tenon's portfolio of minimally invasive technologies for treating sacroiliac $(SI)$ joint conditions, adding to its existing Catamaran SI Joint Fusion System. The SImmetry+ system features new 3D printed titanium implants, a robust joint decorticator, and a simple bone graft delivery system, providing advanced options for physicians. The company is initiating an alpha launch of SImmetry+ with a select group of physician users to gather initial feedback in preparation for a broader market rollout. The clearance further strengthens Tenon's position in the growing SI joint fusion market.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1089573) on October 21, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。